Treatments for hemophilia A patients with inhibitor and acquired hemophilia patients have been fairly limited, and have consisted of fVIII bypass agents [36], immunosuppressive therapy [37], and the infusion of highly purified porcine fVIII (Hyate:C) [38]. This evidence concerns the gene F8 and hemophilia A.